Screener
IDEAYA Biosciences, Inc. IDYA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Research and development | 95,726 | 70,886 |
| General and administrative | 19,378 | 13,503 |
| Total operating expenses | 115,104 | 84,389 |
| Loss from operations | (108,544) | (84,389) |
| Other income | ||
| Interest income and other income, net | 10,005 | 12,211 |
| Net loss | $(98,539) | $(72,178) |
| Unrealized (losses) gains on marketable securities | (2,761) | 773 |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s operating income?
- IDEAYA Biosciences, Inc. (IDYA) reported operating income of -$108.54M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s operating income changed year-over-year?
- IDEAYA Biosciences, Inc.'s operating income decreased by 28.6% year-over-year, from -$84.39M to -$108.54M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s operating income?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s operating income has grown at a 33.4% compound annual growth rate (CAGR), from -$50.27M to -$159.31M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about IDEAYA Biosciences, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude